Literature DB >> 16530932

EAU Guidelines on erectile dysfunction: an update.

Eric Wespes1, Edouard Amar, Dimitrios Hatzichristou, Kosta Hatzimouratidis, Francesco Montorsi, John Pryor, Yoram Vardi.   

Abstract

The introduction of new oral therapies has completely changed the diagnostic and therapeutic approach to erectile dysfunction. A panel of experts in this field has developed guidelines for the clinical evaluation and treatment based on the review of available scientific information.

Entities:  

Mesh:

Year:  2006        PMID: 16530932     DOI: 10.1016/j.eururo.2006.01.028

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  56 in total

1.  Pharmacokinetics of a new orodispersible tablet formulation of vardenafil: results of three clinical trials.

Authors:  Roland Heinig; Boris Weimann; Hartmut Dietrich; Michael-Friedrich Böttcher
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Routine cardiac assessment is not necessary for all patients with erectile dysfunction.

Authors:  Naif Alhathal; Serge Carrier
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

3.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

4.  Are phosphodiesterase type 5 inhibitors effective for the management of lower urinary symptoms suggestive of benign prostatic hyperplasia?

Authors:  Li Tao Zhang; Jong Kwan Park
Journal:  World J Nephrol       Date:  2015-02-06

5.  Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome.

Authors:  Jae Kang; Byeong Kuk Ham; Mi Mi Oh; Je Jong Kim; Du Geon Moon
Journal:  Korean J Urol       Date:  2011-06-17

6.  Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound.

Authors:  G Corona; E Mannucci; A D Fisher; F Lotti; E Bandini; L Vignozzi; G Balercia; F Paggi; L Petrone; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

Review 7.  Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.

Authors:  Sharon A Huang; Janette D Lie
Journal:  P T       Date:  2013-07

Review 8.  The use of phosphodiesterase 5 inhibitors with concomitant medications.

Authors:  G Corona; E Razzoli; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

9.  Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives.

Authors:  Pierre Costa; Thierry Grivel; Naji Gehchan
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

Review 10.  Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Antonio Martín Morales; Vincenzo Mirone; John Dean; Pierre Costa
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.